Federal Register / Vol. 70, No. 198 / Friday, October 14, 2005 / Notices 60093 

Information Collection: Application for 

Participation in the Medicare Care 

Management Performance 

Demonstration; Form Number: CMS–

10165 (OMB#: 0938–0965); Use: The 

Medicare Care Management 

Performance (MCMP) Demonstration 

and its corresponding Report to 

Congress are mandated by the section 

649 of the Medicare Prescription Drug, 

Improvement, and Modernization Act of 

2003 (MMA). Section 649 of the MMA 

provides for the implementation of a 

‘‘pay for performance’’ demonstration 

under which Medicare would pay 

incentive payments to physicians who 

(1) adopt and use health information 

technology; and (2) meet established 

standards on clinical performance 

measures. This demonstration will be 

held in four states, Arkansas, California, 

Massachusetts, and Utah. Providers that 

are enrolled in the Doctors’ Office 

Quality—Information Technology 

(DOQ–IT) project are eligible to 

participate in the demonstration. To 

enroll in the MCMP Demonstration, a 

physician/provider must submit an 

application form. The information 

collected will be used to assess 

eligibility for the demonstration; 

Frequency: Reporting—One-time only; 

Affected Public: Business or other forprofit; Number of Respondents: 800; 

Total Annual Responses: 800; Total 

Annual Hours: 133. 

To obtain copies of the supporting 

statement and any related forms for the 

proposed paperwork collections 

referenced above, access CMS’ Web site 

address at http://www.cms.hhs.gov/ 

regulations/pra/, or E-mail your request, 

including your address, phone number, 

OMB number, and CMS document 

identifier, to Paperwork@cms.hhs.gov, 

or call the Reports Clearance Office on 

(410) 786–1326. 

To be assured consideration, 

comments and recommendations for the 

proposed information collections must 

be received at the address below, no 

later than 5 p.m. on December 13, 2005. 

CMS, Office of Strategic Operations and 

Regulatory Affairs, Division of 

Regulations Development, Attention: 

Melissa Musotto, Room C4–26–05, 7500 

Security Boulevard, Baltimore, 

Maryland 21244–1850. 

Dated: October 6, 2005. 

Michelle Shortt, 

Director, Regulations Development Group, 

Office of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. 05–20517 Filed 10–13–05; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–10064] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, HHS. 

In compliance with the requirement 

of section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995, the 

Centers for Medicare & Medicaid 

Services (CMS), Department of Health 

and Human Services, is publishing the 

following summary of proposed 

collections for public comment. 

Interested persons are invited to send 

comments regarding this burden 

estimate or any other aspect of this 

collection of information, including any 

of the following subjects: (1) The 

necessity and utility of the proposed 

information collection for the proper 

performance of the Agency’s function; 

(2) the accuracy of the estimated 

burden; (3) ways to enhance the quality, 

utility, and clarity of the information to 

be collected; and (4) the use of 

automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

1. Type of Information Collection 

Request: Extension of a currently 

approved collection; Title of 

Information Collection: Minimum Data 

Set (MDS) for Swing Bed Hospitals and 

Supporting Regulations in 42 CFR 

483.20 and 413.337; Form No.: CMS–

10064 (OMB # 0938–0872); Use: As 

required under Section 1888(e)(7) of the 

Social Security Act, swing bed hospitals 

must be reimbursed under the skilled 

nursing facility prospective payment 

system. CMS uses the MDS data to 

reimburse swing bed hospitals for SNFlevel care furnished to Medicare 

beneficiaries. The MDS3.0 is currently 

being developed with plans for field 

testing to begin in 2006 with the 

expectation of completion in 2007. At 

that time, CMS will analyze the data 

derived from the study, including the 

implementation of the new version of 

the MDS for swing bed hospitals. Since 

we do not have the MDS3.0 version 

available, we are requesting an 

extension for the current SB–MDS.; 

Frequency: Reporting—Other (days 5, 

14, 30, 60, and 90 of stay); Affected 

Public: Not-for-profit institutions, and 

State, Local, and Tribal governments; 

Number of Respondents: 820; Total 

Annual Responses: 92,789; Total 

Annual Hours: 51,314. 

To obtain copies of the supporting 

statement and any related forms for 

these paperwork collections referenced 

above, access CMS Web site address at 

http://www.cms.hhs.gov/regulations/ 

pra/, or e-mail your request, including 

your address, phone number, OMB 

number, and CMS document identifier, 

to Paperwork@cms.hhs.gov, or call the 

Reports Clearance Office on (410) 786–

1326. 

To be assured consideration, 

comments and recommendations for the 

proposed information collections must 

be received by the OMB Desk Officer at 

the address below, no later than 5 p.m. 

on November 14, 2005. OMB Human 

Resources and Housing Branch, 

Attention: CMS Desk Officer, New 

Executive Office Building, Room 10235, 

Washington, DC 20503. 

Dated: October 6, 2005. 

Martique S. Jones, 

Acting Director, Regulations Development 

Group, Office of Strategic Operations and 

Regulatory Affairs. 

[FR Doc. 05–20521 Filed 10–13–05; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

Blood Products Advisory Committee; 

Notice of Meeting 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

This notice announces a forthcoming 

meeting of a public advisory committee 

of the Food and Drug Administration 

(FDA). At least one portion of the 

meeting will be closed to the public. 

Name of Committee: Blood Products 

Advisory Committee. 

General Function of the Committee: 

To provide advice and 

recommendations to the agency on 

FDA’s regulatory issues. 

Date and Time: The meeting will be 

held on November 3, 2005, from 8 a.m. 

to 5:30 p.m., and on November 4, 2005, 

from 8 a.m. to 3:30 p.m. 

Location: Holiday Inn Gaithersburg, 2 

Montgomery Village Ave., Gaithersburg, 

MD 20879. 

Contact Person: Donald W. Jehn or 

Pearline K. Muckelvene, Center for 

Biologics Evaluation and Research, 

Food and Drug Administration, 1401 

Rockville Pike, Rockville, MD 20852, 

301–827–0314, or FDA Advisory 

Committee Information Line, 1–800–